Table 2. Serum levels of adipocytokines (pg/mL) in lung cancer patients and controls.
| Adipocytokines | Patients (mean) | Controls (mean) | P value |
|---|---|---|---|
| IGFBP-1 | 148,214.9 | 32,188.9 | 0.00 |
| Resistin | 254,917.2 | 192,906.2 | 0.06 |
| TNF RI | 45,126.3 | 21,141.4 | 0.00 |
| VEGF | 12,093.9 | 4,977.0 | 0.00 |
| TNF RII | 50,876.0 | 33,383.3 | 0.00 |
| Leptin | 11,636.0 | 19,326.2 | 0.38 |
| BDNF | 49,441.4 | 83,516.8 | 0.00 |
| PAI-1 | 13,266.6 | 9,322.7 | 0.01 |
| IL-6 | 12,404.7 | 10,374.1 | 0.01 |
| TNFα | 3,547.9 | 3,597.3 | 0.97 |
| IL-10 | 2,725.7 | 2,360.6 | 0.43 |
| Chemerin | 2,160.6 | 2,386.8 | 0.73 |
P<0.05: the difference was statistically significant. IGFBP-1, insulin-like growth factor binding protein 1; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor; IL, interleukin; BDNF, brain-derived neurotrophic factor; PAI-1, plasminogen activator inhibitor-1.